Stephen F. Konieczny, PhD
Affiliations: | Biological Sciences | Purdue University, West Lafayette, IN, United States |
Google:
"Stephen Konieczny"Bio:
https://www.bio.purdue.edu/people/faculty/faculty_files/15/cv_15.PDF
Mean distance: 11.43
Parents
Sign in to add mentor| John Russell Coleman | grad student | 1977-1982 | Brown | |
| (A somatic cell hybridization approach to the analysis of muscle differentiation) | ||||
| Charles P. Emerson, Jr. | post-doc | 1982-1986 | UVA (FlyTree) | |
Children
Sign in to add trainee| Katherine E. Yutzey | grad student | 1992 | Purdue (Anatomy Tree) |
| Matthew J. Flick | grad student | 1995-2000 | Purdue |
| John M. Rukstalis | grad student | 2003 | Purdue |
| Thai H. Tran | grad student | 2006 | Purdue |
| Liqin Zhu | grad student | 2006 | Purdue |
| Mandar V. Kulkarni | grad student | 2007 | Purdue |
| Di Jia | grad student | 2008 | Purdue |
| Guanglu Shi | grad student | 2010 | Purdue |
| Daniel M. DiRenzo | grad student | 2012 | Purdue |
| David A. Hess | grad student | 2013 | Purdue |
| Yi Yang | grad student | 2012-2019 | Purdue |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wöhner M, Pinter T, Bönelt P, et al. (2022) The Xbp1-regulated transcription factor Mist1 restricts antibody secretion by restraining Blimp1 expression in plasma cells. Frontiers in Immunology. 13: 859598 |
| Zhang Z, Cheng L, Li J, et al. (2022) Targeting Plk1 sensitizes pancreatic cancer to immune checkpoint therapy. Cancer Research |
| Venis SM, Moon HR, Yang Y, et al. (2021) Engineering of a functional pancreatic acinus with reprogrammed cancer cells by induced expression. Lab On a Chip. 21: 3675-3685 |
| Schweickert PG, Wang N, Sandefur SL, et al. (2020) CRISPR/Ca12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction. Biotechnology Journal. e2000308 |
| Schweickert PG, Yang Y, White EE, et al. (2020) Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. Journal of Thrombosis and Haemostasis : Jth |
| Moon HR, Ozcelikkale A, Yang Y, et al. (2020) An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations. Lab On a Chip |
| Moon HR, Ospina-Muñoz N, Noe-Kim V, et al. (2020) Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform. Plos One. 15: e0234012 |
| Bradney MJ, Venis SM, Yang Y, et al. (2020) A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma. Small (Weinheim An Der Bergstrasse, Germany). e1905500 |
| Yang Y, Stang A, Schweickert PG, et al. (2019) Thrombin signaling promotes pancreatic adenocarcinoma through PAR-1-dependent immune evasion. Cancer Research |
| Shouksmith AE, Shah F, Grimard ML, et al. (2019) Identification and Characterization of AES-135, a Hydroxamic Acid-based HDAC Inhibitor that Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. Journal of Medicinal Chemistry |